Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
暂无分享,去创建一个
T. Yoshikawa | J. Sakamoto | K. Tanabe | S. Morita | Tsutomu Hayashi | Yuichi Ito | A. Tsuburaya | K. Fujitani | J. Fujita | Y. Kimura | K. Nishikawa | T. Aoyama | T. Matsui | Haruhiko Cho | Y. Miyashita